相关实验视频

Updated: Jun 11, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

皮肤黑色素瘤进展中的氧化状态:平衡问题

Mascia Benedusi¹, Heaji Lee², Yunsook Lim²

¹Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

Antioxidants (Basel, Switzerland)

|September 28, 2024

概括

反应性氧物种 (ROS) 对黑色素瘤产生影响,过度生产可能导致瘤生长或亡. 这项研究探讨了ROS.

科学领域:

在瘤学瘤学.
生物化学生物化学
皮肤病学皮肤病学

背景情况:

反应性氧物种 (ROS) 是生理过程的关键调节者,并与包括癌症在内的各种疾病有关.
皮肤黑色素瘤是一种高度攻击性的皮肤癌,与紫外线 (UV) 辐射暴露和过度的ROS产生密切相关.
在黑色素瘤转移中ROS的确切作用仍然不完全理解,有证据表明它既具有前瘤原生作用,也具有细胞毒性作用.

研究的目的:

研究细胞氧化还原状态和控制黑色素瘤转移的信号通路之间的复杂关系.
审查和讨论氧化和抗氧化治疗策略的潜力,以管理转移性黑色素瘤.

主要方法:

文献综述和对ROS,黑色素瘤进展和治疗干预措施的现有研究进行分析.
在黑色素瘤转移的背景下,探索受细胞氧化还原平衡影响的信号通路.

主要成果:

矛盾的是,在黑色素瘤中过度产生的ROS可以促进瘤细胞的增殖和治疗抵抗.
相反,较高的ROS水平也可以诱导黑色素瘤细胞的亡,突出显示其双重作用.
确定了将氧化还原状态与转移过程联系起来的特定信号通路,以便进一步调查.

结论:

ROS在黑色素瘤进展中的双重作用需要对有效的治疗向进行细微了解.
准细胞氧化还原状态为针对转移性黑色素瘤的新型治疗策略提供了一个有希望的途径.
进一步的研究对于阐明ROS和黑色素瘤转移之间的复杂相互作用至关重要.

关键词:

抗氧化剂/亲氧化剂疗法人类癌症人类癌症黑色素瘤的进展情况反应性氧物种 (ROS) 是一种反应性氧物种.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...